Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: A prospective, multicentre trial

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 3, 2012, Pages 387-395

  Acampa, Wanda ^a,b   Petretta, Mario ^a   Evangelista, Laura ^a   Daniele, Stefania ^c   Xhoxhi, Evgjeni ^a   De Rimini, Maria Luisa ^d   Cittanti, Corrado ^e   Marranzano, Filippo ^f   Spadafora, Marco ^g   Baldari, Sergio ^h   Mansi, Luigi ⁱ   Cuocolo, Alberto ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS SDN   (Italy)

^d MONALDI HOSPITAL   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g S G MOSCATI HOSPITAL   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiac risk classification; Diabetes mellitus; Gated SPECT; Myocardial perfusion imaging; Net reclassification improvement

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MYOCARDIAL PERFUSION IMAGING; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RETINOPATHY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; UNSTABLE ANGINA PECTORIS;

COHORT STUDIES; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; RISK ASSESSMENT; RISK FACTORS; STRESS, PHYSIOLOGICAL; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84859635330     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1983-x     Document Type: Article

References (32)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34. (Pubitemid 28350165)
2. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care. 1999;22:1396-400. (Pubitemid 29418229)
3. May O, Arildsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population-based study. Cardiovasc Res. 1997;34:241-7. (Pubitemid 27261935)
4. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900-7.
5. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 1999;137:949-57. (Pubitemid 29226307)
6. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105:32-40. (Pubitemid 34049139)
7. Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium- 99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol. 2006;97:1538-44.
8. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890-6. (Pubitemid 38881004)
9. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care. 1998;21:1551-9.
10. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954-61. (Pubitemid 38989238)
11. Petretta M, Acampa W, Evangelista L, Daniele S, Ferro A, Cuocolo A. Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: rationale and design of a prospective, multicenter trial. J Nucl Cardiol. 2008;15:100-4.
12. Pencina MJ, D'Agostino RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-72. (Pubitemid 351193639)
13. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768-77.
14. Shaw LJ. The new era of risk reclassification in cardiovascular imaging. J Nucl Cardiol. 2011;18:536-7.
15. Shaw LJ, Wilson PWF, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging. 2010;3:1139-48.
16. Diamond GA, Staniloff HM, Forrester JS, Pollok BH, Swan HJ. Computer assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol. 1983;1:444-55. (Pubitemid 13063197)
17. Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32:855-97. (Pubitemid 41125431)
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-42. (Pubitemid 34262671)
19. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I: Technical principles and reproducibility. J Nucl Med. 2000;41:712-9. (Pubitemid 30207750)
20. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535-43. (Pubitemid 28090682)
21. Harrell Jr FE. Predicting outcomes: applied survival analysis and logistic regression. Charlottesville, VA: University of Virginia; 2000.
22. Grundy SM, Pasternak R, Greenland P, Smith Jr S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481-92. (Pubitemid 29451714)
23. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med. 2009;26:142-8.
24. Saely CH, Aczel S, Koch L, Schmid F, Marte T, Huber K, et al. Diabetes as a coronary artery disease risk equivalent: before a change of paradigm? Eur J Cardiovasc Prev Rehabil. 2010;17:94-9.
25. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547-55.
26. Bansal S, Wackers FJ, Inzucchi SE, Chyun DA, Davey JA, Staib LH, et al. Five-year outcomes in high-risk participants in theDetection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis. Diabetes Care. 2011;34:204-9.
27. Zellweger MJ, Hachamovitch R, Kang X, Hayes SW, Friedman JD, Germano G, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004;25:543-50. (Pubitemid 38478546)
28. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54:17-23. (Pubitemid 351182592)
29. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611-9.
30. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;30:1610-6.
31. Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol. 2006;48:761-4. (Pubitemid 44175712)
32. Winocour PH, Fisher M. Prediction of cardiovascular risk in people with diabetes. Diabet Med. 2003;20:515-27. (Pubitemid 36886464)